XYLO
xylo.bio
Actively hiring
Drug Discovery
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
Lionheart Ventures
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs FluoSphera SA
backs Sequence Bio
backs Sequence Bio
backs Khumbu.ai
backs NeuraLight
backs FluoSphera SA
Similar startupsby what they do, their industry and backers
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
Metanova Labs is an AI drug discovery company building a new model for discovering and developing novel therapeutics. Through NOVA, its…
AI-first biotech accelerating early drug discovery with protein–ligand insights and advanced models for molecular understanding. Khumbu.ai.
Biology meets artificial and human intelligence for next-generation therapeutics. Onava is built differently. Our platform compounds in…
Advanced 3D and multi-tissue biology for predictive drug discovery. Ready-to-use microtissues for efficacy, safety, DMPK-Tox & biomarker…
ABOUT US IteriaBiopharma is a privately owned Spanish biotech founded in 2024 by a team of experienced entrepreneurs in drug discovery and…